The global artificial pancreas devices systems market was valued at $0.4 billion in 2023, and is projected to reach $0.8 billion by 2033, growing at a CAGR of 8.8% from 2024 to 2033.
The global cellulite reduction devices market was valued at $0.3 billion in 2023, and is projected to reach $1.0 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
